Nareg Sagherian | Executive Director, Investor Relations |
Jerry Durso | President and Chief Executive Officer |
Dr. Michelle Berrey | President, Research & Development and Chief Medical Officer |
Andrew Saik | Chief Financial Officer |
Linda Richardson | Chief Commercial Officer |
Yasmeen Rahimi | Piper Sandler |
Mayank Mamtani | B. Riley Securities |
Ritu Baral | Cowen |
Ryan Deschner | Raymond James |
Joseph Stringer | Needham and Company |
Brian Skorney | R.W. Baird |
Thomas Smith | SVB Securities |
Jon Wolleben | JMP Securities |
Ellie Merle | UBS |
Michael Yee | Jefferies |
Brian Abrahams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Ed Arce | H.C. Wainwright |
Good day and thank you for standing by. Welcome to the First Quarter 2023 Intercept Pharmaceuticals Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and answer-session. [Operator Instructions] Please be advised that today's conference is being recorded.